Pharma Stocks
-
Why Big Pharma Won’t Quit the Diet. Who Will Win the Next Weight Loss Battle?
Chances are you know someone on a weight loss injectable. In fact, nearly 12% of Americans are using, or have…
Read More » -
Why Is Arrowhead Pharma Stock Soaring Tuesday? – Arrowhead Pharma (NASDAQ:ARWR)
The U.S. Food and Drug Administration (FDA) has approved Arrowhead Pharmaceuticals, Inc.’s (NASDAQ:ARWR) Redemplo (plozasiran), a small interfering RNA (siRNA)…
Read More » -
Terns Pharmaceuticals (TERN) Soars to New Record High of $26.12
We recently published 10 Firms Shining Bright in a Bleeding Market. Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is one of the best-performing…
Read More » -
Assessing Crinetics Pharmaceuticals (CRNX) Valuation After Recent Share Price Slide and Revenue Growth
Crinetics Pharmaceuticals (CRNX) shares have seen mixed movement over the past month, even as the company continues to report strong…
Read More » -
Analysts Are Updating Their Mankind Pharma Limited (NSE:MANKIND) Estimates After Its Second-Quarter Results
Last week, you might have seen that Mankind Pharma Limited (NSE:MANKIND) released its quarterly result to the market. The early…
Read More » -
Kissei Pharmaceutical (TSE:4547) Valuation in Focus After Strong H1 Results and Upgraded Outlook
Kissei Pharmaceutical (TSE:4547) shares are drawing attention after the company reported a 7.9% year-over-year jump in net sales for the…
Read More » -
Companies Like Hyloris Pharmaceuticals (EBR:HYL) Are In A Position To Invest In Growth
There’s no doubt that money can be made by owning shares of unprofitable businesses. For example, although software-as-a-service business Salesforce.com…
Read More » -
Why Neuren Pharmaceuticals (ASX:NEU) Is Down 14.6% After Revised DAYBUE Sales and Royalty Outlook
Earlier this week, Neuren Pharmaceuticals announced record Q3 2025 DAYBUE™ sales of US$101.1 million and provided an updated royalty outlook…
Read More » -
ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Strong Q3 Numbers, Stock Soars
Specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 53.6% year…
Read More » -
Why Amphastar Pharmaceuticals (AMPH) Stock Is Up Today
What Happened? Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) jumped 4.9% in the afternoon session after the company reported third-quarter…
Read More »
